668 related articles for article (PubMed ID: 33717128)
1. The Immunopathology of Giant Cell Arteritis Across Disease Spectra.
Robinette ML; Rao DA; Monach PA
Front Immunol; 2021; 12():623716. PubMed ID: 33717128
[TBL] [Abstract][Full Text] [Related]
2. [Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects].
Chaigne-Delalande S; de Menthon M; Lazaro E; Mahr A
Presse Med; 2012 Oct; 41(10):955-65. PubMed ID: 22940467
[TBL] [Abstract][Full Text] [Related]
3. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.
Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
Arthritis Res Ther; 2019 Dec; 21(1):304. PubMed ID: 31888748
[TBL] [Abstract][Full Text] [Related]
4. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
[TBL] [Abstract][Full Text] [Related]
5. Temporal small arterial inflammation is common in patients with giant cell arteritis.
Zhao CL; Hui Y; Amin A
Hum Pathol; 2018 Nov; 81():65-70. PubMed ID: 29953896
[TBL] [Abstract][Full Text] [Related]
6. [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].
Villiger PM
Z Rheumatol; 2017 Aug; 76(6):509-523. PubMed ID: 28638968
[TBL] [Abstract][Full Text] [Related]
7. The pathology of large-vessel vasculitides.
Miller DV; Maleszewski JJ
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S92-8. PubMed ID: 21586202
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of large vessel vasculitides].
Arnold S; Holl Ulrich K; Lamprecht P
Z Rheumatol; 2020 Aug; 79(6):505-515. PubMed ID: 32430566
[TBL] [Abstract][Full Text] [Related]
9. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
[TBL] [Abstract][Full Text] [Related]
10. Role of
Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
[TBL] [Abstract][Full Text] [Related]
11. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
Maksimowicz-McKinnon K; Clark TM; Hoffman GS
Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.
Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C
Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007
[TBL] [Abstract][Full Text] [Related]
13. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
14. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis.
Grayson PC; Maksimowicz-McKinnon K; Clark TM; Tomasson G; Cuthbertson D; Carette S; Khalidi NA; Langford CA; Monach PA; Seo P; Warrington KJ; Ytterberg SR; Hoffman GS; Merkel PA;
Ann Rheum Dis; 2012 Aug; 71(8):1329-34. PubMed ID: 22328740
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and differential diagnosis of large-vessel vasculitides.
Keser G; Aksu K
Rheumatol Int; 2019 Feb; 39(2):169-185. PubMed ID: 30221327
[TBL] [Abstract][Full Text] [Related]
16. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
Kermani TA; Crowson CS; Muratore F; Schmidt J; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2015 Jun; 44(6):724-8. PubMed ID: 25712813
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.
van Sleen Y; Wang Q; van der Geest KSM; Westra J; Abdulahad WH; Heeringa P; Boots AMH; Brouwer E
Sci Rep; 2017 Jul; 7(1):6553. PubMed ID: 28747747
[TBL] [Abstract][Full Text] [Related]
18. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis.
Wagner AD; Wittkop U; Prahst A; Schmidt WA; Gromnica-Ihle E; Vorpahl K; Hudson AP; Zeidler H
Clin Exp Rheumatol; 2003; 21(2):185-92. PubMed ID: 12747272
[TBL] [Abstract][Full Text] [Related]
20. Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease?
Kermani TA
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():41-48. PubMed ID: 29624864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
